Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Progyny

Progyny

PGNY

0.00

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ: PGNY) with a Equal-Weight and lowers the price target from $34 to $30.